Geotrichum Allergy Shots: When Cheesemakers' Lungs — Not Allergy Shots — Come First
Geotrichum candidum is the yeast-like fungus integral to Camembert and Brie production — and a human commensal found in 30% of normal stool and skin specimens. Occupational allergy to Geotrichum is documented in dairy workers; positive tests in non-occupationally-exposed patients usually reflect commensal colonization rather than meaningful sensitization. No WHO/IUIS Geotrichum allergens are registered, and no SCIT RCT has been published.
Geotrichum candidum Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to geotrichum candidum — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of geotrichum candidum allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of geotrichum candidum immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of geotrichum candidum extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for geotrichum candidum allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing geotrichum candidum extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription geotrichum candidum immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat geotrichum candidum allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Geotrichum candidum?
The biology, taxonomy, and clinical fingerprint of Geotrichum candidum — the foundation of how SCIT targets it.
Geotrichum candidum produces characteristic barrel-shaped arthroconidia and is integral to the fermentation of surface-ripened cheeses including Camembert and Brie.
- Scientific name
- Geotrichum candidum (teleomorph: Galactomyces candidus)
- Family
- DipodascaceaeSaccharomycetales order
- Type
- Yeast-like fungus — dairy industry fermentation organism and human commensal
- Native to
- Ubiquitous; dairy processing environments, human GI tract and skin, soil, and decaying organic matter worldwide
- Allergen proteins
- No WHO/IUIS-registered Geotrichum allergens as of 2024Cross-reactivity within Saccharomycetales via shared yeast cell wall components (Crameri 2014)
- Particle size
- Barrel-shaped arthroconidia 6-12 x 3-6 µm
- Avoidance difficulty
- Moderate
How Geotrichum candidum Allergy Presents
Symptoms by body system — useful for distinguishing Geotrichum candidum sensitivity from overlapping allergies and infections.
Respiratory
- Occupational rhinitis in cheese-ripening room workers during high-arthroconidia periods
- Occupational asthma in dairy plant workers with intense Geotrichum exposure
- Cough and bronchospasm in cheesemakers during arthrospore-generating processing steps
- Non-specific respiratory symptoms in library/archive workers with secondary mold colonization
Ocular
- Occupational conjunctivitis in dairy workers with heavy inhalation exposure
- Eye irritation during cheese-ripening room work with high arthroconidia concentrations
- Tearing during processing of surface-ripened cheeses
Dermal
- Skin sensitization from direct contact with Geotrichum-containing cheese rind material
- Non-specific dermatitis in occupationally exposed workers
- Geotrichosis (rare opportunistic skin infection in immunocompromised) — not allergy related
Systemic
- Fatigue from chronic occupational exposure in poorly ventilated dairy ripening rooms
- Sleep disruption secondary to occupational rhinitis
- Reduced work capacity in severely sensitized dairy workers
- Geotrichosis systemic infection in immunocompromised — >60% mortality in oncological patients (Pottier 2008); entirely outside allergy scope
In 20 years of practice, Geotrichum positive results in patients without dairy occupational exposure have never changed my treatment plan. The commensal carriage rate in normal individuals is 30%, which inflates panel positivity without clinical meaning. For cheesemakers and dairy plant workers, the conversation is about protective equipment in the ripening rooms first — and whether the remaining symptoms after exposure control warrant further management.
Where Geotrichum candidum Triggers Year-Round
Geotrichum candidum is a perennial trigger — exposure is constant for sensitized patients. Geographic intensity still varies by climate.
12-Month Intensity
Year-roundYear-round occupational exposure in dairy plants; commensal carriage is constant regardless of season· Perennial for occupational workers; commensal exposure is constant in all individuals regardless of occupation
US Exposure Map
0 high-intensity statesWhat Geotrichum candidum Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Geotrichum candidum has no formally characterized allergen-specific cross-reactivity. Pan-fungal cross-reactivity within Saccharomycetales is plausible via shared yeast cell wall components — mannans, beta-glucans — but is poorly characterized in the allergy literature.
Is SCIT Right for Your Geotrichum candidum Allergy?
Answer these questions to determine whether your Geotrichum positive is likely an occupational finding warranting further evaluation or a commensal artifact without therapeutic implication.
Do you work in a dairy plant, cheese facility, or library/archive setting with potential Geotrichum exposure?
The Geotrichum candidum SCIT Protocol
SCIT is not standardly indicated for Geotrichum candidum. For severe occupational dairy asthma where exposure modification has been optimized and symptoms persist, family-level mold mix SCIT may be considered with explicit evidence-gap acknowledgment. Non-occupational patients should not be offered SCIT for Geotrichum.
If mold mix SCIT is considered for severe occupational dairy asthma, standard mold build-up applies with a 30-minute observation period. Mold vials separated from pollen extracts. Concurrent exposure modification (PPE, ventilation) is first-line throughout.
Maintenance injections continue monthly or every 2-4 weeks. Occupational health follow-up for PPE compliance and exposure measurement is concurrent.
Continuation decision accounts for ongoing occupational exposure level and symptom trajectory.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Geotrichum candidum SCIT
No published SCIT RCT exists for Geotrichum candidum. No WHO/IUIS allergens are registered. Evidence for any treatment beyond exposure modification in occupational Geotrichum allergy is anecdotal.
- Occupational exposure control — estimated symptom reduction for dairy Geotrichum sensitization50%Skórska C, et al. Allergic alveolitis in agricultural workers. Ann Agric Environ Med 2007;14(2):205-214.
No SCIT RCT has been published for Geotrichum candidum. For occupationally exposed dairy and cheesemaker patients, exposure modification (PPE, ventilation, job rotation) provides the most meaningful symptom reduction. Family-level mold mix SCIT is a clinical-judgment consideration for severe occupational asthma where exposure modification has been exhausted; this decision carries no dedicated trial support.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Geotrichum candidum SCIT Side Effects
If mold mix SCIT is pursued for occupational Geotrichum sensitization, standard mold SCIT side-effect parameters apply.
Local reactions
4 documentedSystemic reactions
4 documentedAll mold SCIT requires epinephrine available and a mandatory 30-minute observation period — with Curex, you self-observe at home with a prescribed epinephrine auto-injector, and the first injection and every dose change are Zoom-supervised by the care team. For occupational patients with asthma, pre-injection peak flow measurement is required.
SCIT vs Alternatives for Geotrichum candidum
For Geotrichum occupational allergy, exposure control is the primary and most effective intervention. SCIT is a distant clinical-judgment consideration for severe cases where exposure cannot be adequately controlled.
| Criterion | Occupational exposure controlBest | SCIT (mold mix, occupational only) | SLIT drops | Medications |
|---|---|---|---|---|
| Effectiveness | Primary and most effective intervention for occupational cases | Anecdotal — no Geotrichum-specific RCT | No Geotrichum SLIT data | Symptomatic control only |
| 5-yr cost | PPE/ventilation costs variable | $3,500-$8,000 over 5 years | $500-$2,000/yr | $500-$2,000/yr ongoing |
| Duration | Ongoing workplace modification | 3-5 years | 3-5 years | Ongoing |
| Convenience | Employer cooperation required | Weekly then monthly clinic visits | Daily at-home use | Daily pills/sprays |
| Safety | No injection risks | Systemic reactions <1% | Lower systemic reaction risk | Drug side effects long-term |
| Lasting effect | Effective while controls maintained | Uncertain for this organism | Evidence not established | No lasting effect |
Occupational exposure controlBest
SCIT (mold mix, occupational only)
SLIT drops
Medications
Occupational exposure control is the most effective strategy for Geotrichum-sensitized dairy workers. For patients who work in settings where PPE improvement is difficult, Curex at-home allergy testing helps occupational patients confirm Geotrichum sensitization patterns without disrupting their work schedule. If mold immunotherapy is ultimately pursued, Curex delivers SCIT as weekly at-home self-injections at $129/month — with allergist oversight via telehealth, a prescribed epinephrine auto-injector confirmed on hand, and Zoom-supervised dosing for the first injection and every dose change — to discuss with your allergist, though evidence is limited for this specific organism.
What Geotrichum candidum SCIT Actually Costs
Curex at-home testing helps occupational patients such as cheesemakers and dairy workers confirm Geotrichum sensitization without taking time off during peak production cycles. Workers' compensation coverage may apply for confirmed occupational disease; standard allergy benefits cover testing and pharmacotherapy.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your geotrichum candidum allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Geotrichum candidum SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Yes, entirely normal. Geotrichum candidum is found in approximately 30% of normal human fecal, skin, sputum, and oral specimens in healthy individuals without any allergy or disease implication. This commensal carriage is the primary reason a Geotrichum positive on an allergy panel does not automatically indicate a clinically meaningful allergy — especially in patients without occupational dairy or food-industry exposure. The organism is present in soil, dairy products, and decaying organic matter worldwide; ubiquitous environmental and GI contact explains routine low-level IgE responses in atopic individuals without pathological significance.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.